A case series of DKA occurring in patients receiving treatment with SGLT-2 inhibitors

Diabetes Obes Metab. 2018 Jul;20(7):1800-1801. doi: 10.1111/dom.13271. Epub 2018 Mar 22.

Authors

Jawad Bashir¹, Preethi Nalla¹, Rajesh Peter², Stephen C Bain³, Richard Chudleigh²

Affiliations

¹ Department of Diabetes and Endocrinology, University Hospital of Wales, Cardiff, UK.
² Department of Diabetes and Endocrinology, Singleton Hospital, Swansea, UK.
³ Diabetes Research Group, School of Medicine, Swansea University, Swansea, UK.

PMID: 29493069
DOI: 10.1111/dom.13271

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Benzhydryl Compounds / adverse effects
Canagliflozin / adverse effects
Diabetes Mellitus, Type 2 / drug therapy*
Diabetic Ketoacidosis / chemically induced*
Female
Glucosides / adverse effects
Humans
Latent Autoimmune Diabetes in Adults / diagnosis
Latent Autoimmune Diabetes in Adults / immunology
Male
Middle Aged
Sodium-Glucose Transporter 2 Inhibitors / adverse effects*
United Kingdom

Substances

Benzhydryl Compounds
Glucosides
Sodium-Glucose Transporter 2 Inhibitors
Canagliflozin
dapagliflozin
empagliflozin